Artivion (AORT) Stock: Buy, Sell, or Hold?

AORT - Artivion, Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$22.92
-0.02 (-0.09%) â–ŧ
5d: +0.09%
30d: +0.26%
90d: -17.17%
WAIT
LOW Confidence
Protect Your AORT Gains
Analysis Updated: Oct 28, 2026 12:00 AM ET
Earnings: Nov 05, 2026 7d

Get Alerted When AORT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: AORT is fairly priced but lacks strong directional signals. At -5.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$36.43
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.62
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: AORT is currently trading at $22.92, which is considered fair relative to its 30-day fair value range of $21.73 to $23.34. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.6) compared to its historical average (36.2). Remarkably, the market is currently pricing in an annual earnings decline of 5.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, AORT is showing sideways momentum. Immediate support is located at $21.52, while resistance sits at $24.24.

Market Sentiment: AORT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $40.91 (+78.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $21.73 - $23.34
Company Quality Score 43/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 59.6%

Protect Your Profits

Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 78.5% below Wall St target ($40.91)
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $21.73 - $23.34
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$1.94 (8.5%)

Support & Resistance Levels

Support Level $21.52
Resistance Level $24.24
Current Trend Sideways
Technical data as of Oct 28, 2026

Fundamental Context

Forward P/E (Next Year Est.) 30.63
Wall Street Target $40.91 (+78.5%)
Revenue Growth (YoY) 11.3%
Profit Margin -0.7%
Valuation Discount vs History -5.4% cheaper
PE vs Historical 30.6 vs 36.2 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -5.4% (market-implied from PE analysis)
1-Year Target $21.68 (-5%)
2-Year Target $20.51 (-11%)
3-Year Target $19.40 (-15%)
3-Yr Target (if PE normalizes) (PE: 31→36) $22.93 (+0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 30.6, Growth: 88.0%) $77.36 (+238%)
Base: (SPY PE: 19.9, Growth: 88.0%) $50.16 (+119%)
Bear: (PE: 16.9, Growth: 88.0%) $42.63 (+86%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.6 to 36.2
Stabilization Target: $27.09 (+18.2%)
PE Expansion Potential: +18.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 28, 2026 6:23 PM ET
Data refreshes hourly during market hours. Next update: 7:23 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AORT.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$96 57 HOLD
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$101 53 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 50 HOLD
SYK
Stryker Corporation
STRONG BUY
29 analysts
$363 38 SELL
GEHC
GE HealthCare Technologiâ€Ļ
STRONG BUY
22 analysts
$83 32 SELL

Advanced AORT Option Strategies

Professional options setups generated by AI based on today's AORT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for AORT

AORT Technical Chart AORT Price Prediction AORT Earnings Date AORT Investment Advisor AORT Fair Price Analyzer AORT Options Advisor AORT Options Chain AORT Options Analysis AORT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals